Kevin McLaughlin
Director/Board Member bei VERICEL CORPORATION
Vermögen: 452 574 $ am 31.03.2024
Profil
Kevin F. McLaughlin, Gründer von Aptius Education, Inc. ist derzeit Chief Financial Officer, Treasurer & Senior VP von Acceleron Pharma, Inc. Er ist außerdem im Vorstand von Vericel Corp. und Stealth BioTherapeutics Corp. sowie von Stealth BioTherapeutics, Inc. In seiner bisherigen Laufbahn bekleidete er die Position des Chief Operating Officer & Director bei Aptius Education, Inc, Chief Financial Officer & Senior Vice President bei Qteros, Inc, Chief Executive Officer & Director bei Praecis Pharmaceuticals, Inc, Chief Financial Officer & Vice President bei Advanced TechCom, Inc, Treasurer & Vice President bei Computervision Corp. und Treasurer & Vice President bei Prime Computer, Inc. Kevin F. McLaughlin erhielt einen Undergraduate-Abschluss von der Northeastern University und einen MBA vom Babson College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERICEL CORPORATION
0,02% | 08.03.2024 | 8 700 ( 0,02% ) | 452 574 $ | 31.03.2024 |
Aktive Positionen von Kevin McLaughlin
| Unternehmen | Position | Beginn |
|---|---|---|
| VERICEL CORPORATION | Director/Board Member | 06.01.2015 |
| STEALTH BIOTHERAPEUTICS CORP | Director/Board Member | 14.03.2017 |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Director/Board Member | 01.03.2017 |
Combined Therapeutics, Inc.
 Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Combined Therapeutics, Inc. engages in biotechnology industry group. The company was founded by Romain Micol, Robert Langer, and Dan Anderson in and is headquartered in North Cambridge, MA. | Director/Board Member | 08.03.2023 |
Ehemalige bekannte Positionen von Kevin McLaughlin
| Unternehmen | Position | Ende |
|---|---|---|
| DECIBEL THERAPEUTICS, INC. | Director/Board Member | 22.09.2023 |
| ACCELERON PHARMA INC. | Director of Finance/CFO | 01.12.2021 |
Qteros, Inc.
 Qteros, Inc. Chemicals: SpecialtyProcess Industries Qteros, Inc. develops cellulosic ethanol transportation fuel. The firm utilizes a Q Microbe that converts all fermentable components of biomass to ethanol. The company was founded by Stephan Rogers, Jeffrey Hausthor, Susan Leschine, Jonathan Gorham, John Fabel and Jeffrey C. Sharp in 2006 and is headquartered in Amherst, MA. | Director of Finance/CFO | - |
| Aptius Education, Inc. | Founder | 01.01.2009 |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Chief Executive Officer | 01.01.2007 |
Ausbildung von Kevin McLaughlin
| Babson College | Masters Business Admin |
| Northeastern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Computervision Corp.
 Computervision Corp. Packaged SoftwareTechnology Services Computervision Corporation is a private company that supplies electonic product definition solutions for company computer systems. The company is headquartered in Bedford, MA. | Technology Services |
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Prime Computer, Inc.
 Prime Computer, Inc. Computer Processing HardwareElectronic Technology Prime Computer, Inc. manufactures mini computers and electronic components. It offers printers, projectors, consumer electronics, used monitors & desktop systems, software, protectors and video cards. The company was founded in 1972 and is headquartered in Marietta, GA. | Electronic Technology |
Advanced TechCom, Inc.
 Advanced TechCom, Inc. Telecommunications EquipmentElectronic Technology Part of World Access, Inc. (Georgia), Advanced TechCom, Inc. designs, manufactures and markets a line of digital microwave and millimeterwave radio systems. The private company is based in Wilmington, MA. Advanced TechCom was acquired by World Access, Inc. (Georgia) on January 29, 1998 for $11.31 million. | Electronic Technology |
Qteros, Inc.
Qteros, Inc. Chemicals: SpecialtyProcess Industries Qteros, Inc. develops cellulosic ethanol transportation fuel. The firm utilizes a Q Microbe that converts all fermentable components of biomass to ethanol. The company was founded by Stephan Rogers, Jeffrey Hausthor, Susan Leschine, Jonathan Gorham, John Fabel and Jeffrey C. Sharp in 2006 and is headquartered in Amherst, MA. | Process Industries |
| Aptius Education, Inc. | |
Combined Therapeutics, Inc.
Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Combined Therapeutics, Inc. engages in biotechnology industry group. The company was founded by Romain Micol, Robert Langer, and Dan Anderson in and is headquartered in North Cambridge, MA. | Commercial Services |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The private company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Health Technology |
